CIK 0001783183
- Non-accelerated filer
- Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824151574
- Phone
- +1 877-742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-19 | KARBE FRANK Director | Grant or award | +24,122 | 91,622 | ||
| 2025-06-03 | KARBE FRANK Director | Grant or award | +10,500 | 67,500 | ||
| 2025-06-03 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2024-12-13 | KARBE FRANK Director | Purchase | +12,500 | $7.93 | $99K | 57,000 |
| 2024-05-29 | KARBE FRANK Director | Grant or award | +25,000 | $10.16 | $254K | 44,500 |
| 2024-05-23 | KARBE FRANK Director | Grant or award | +10,500 | 19,500 | ||
| 2024-05-23 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | −17,500 | 17,500 | ||
| 2023-05-25 | KARBE FRANK Director | Grant or award | +9,000 | 9,000 | ||
| 2023-05-25 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-25 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-04-25 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 1 of 1 · 11 trades